Benzyl methyl(1-(1-methylpiperidin-4-yl)-3-(pyrrolidin-1-yl)propan-2-yl)carbamate

Catalog No. :
ACAQKF291
CAS No. :
886363-02-6
Molecular Formula :
C22H35N3O2
Molecular Weight :
373.54

IUPAC Name:benzyl methyl(1-(1-methylpiperidin-4-yl)-3-(pyrrolidin-1-yl)propan-2-yl)carbamate

Benzyl methyl(1-(1-methylpiperidin-4-yl)-3-(pyrrolidin-1-yl)propan-2-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg96%$316.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBenzyl methyl(1-(1-methylpiperidin-4-yl)-3-(pyrrolidin-1-yl)propan-2-yl)carbamate
IUPAC Namebenzyl methyl(1-(1-methylpiperidin-4-yl)-3-(pyrrolidin-1-yl)propan-2-yl)carbamate
MDL No.MFCD03426438
Molecular FormulaC22H35N3O2
Molecular Weight373.54
SMILESO=C(OCC1=CC=CC=C1)N(C)C(CC2CCN(C)CC2)CN3CCCC3
InChI KeyRWNSCXSOKSKTEF-UHFFFAOYSA-N
SynonymMethyl-[1-(1-Methyl-piperidin-4-ylMethyl)-2-pyrrolidin-1-yl-ethyl]-carbaMic acid;METHYL-[1-(1-METHYL-PIPERIDIN-4-YLMETHYL)-2-PYRROLIDIN-1-YL-ETHYL]-CARBAMIC ACID BENZYL ESTER;Carbamic acid, methyl[1-[(1-methyl-4-piperidinyl)methyl]-2-(1-pyrrolidinyl)ethyl]-, phenylmethyl ester (9CI);Benzylmethyl(1-(1-methylpiperidin-4-yl)-3-(pyrrolidin-1-yl)propan-2-yl)carbamate
CAS No.886363-02-6

Synthetic Route by SureRoute

1. ACAQKF291 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAQKF291 route product structure diagram
    ACAQKF291886363-02-6
Inquiry

2. ACAQKF291 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAQKF291 route product structure diagram
    ACAQKF291886363-02-6
Inquiry

Comments (0)